AZAleksandr Zolotarev

Aleksandr Zolotarev

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aleksandr Zolotarev has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sex-Stratified Machine Learning for the Prediction of Post-COVID Condition: A Longitudinal Cohort Study

    by Mikhail I. Krivonosov, Ekaterina Pazukhina, Mikhail Rumyantsev, Elina Abdeeva, Dina Baimukhambetova, Polina Bobkova, Yasmin El-Taravi, Maria Pikuza, Anastasia Trefilova, Aleksandr Zolotarev, et al.

    Background: Post-COVID-19 condition (PCC) affects many survivors, with evidence of sex-specific differences in prevalence and symptom profiles. However, few prediction studies have examined whether sex-stratified models improve prediction or generalize across sexes. This study aimed primarily to develop and compare sex-stratified machine learning models for PCC prediction using routinely available baseline variables, and secondarily to assess cross-sex generalizability and adversarial robustness. Methods: We analyzed a prospective longitudinal cohort of 1006 adults hospitalized with COVID-19 at Sechenov University Hospital Network (Moscow, Russia). Demographics, smoking status, and pre-existing comorbidities were extracted from medical records, and PCC status was assessed at 6-month follow-up. Machine learning models—including classical algorithms and graph-based neural networks—were trained separately for males and females. Cross-sex validation evaluated generalizability, variable importance aided interpretation, and adversarial perturbations assessed model robustness. Results: PCC prevalence was higher in females (53.9%) than males (39.1%). Overall predictive performance was modest across all models, with AUC values ranging approximately 0.50–0.61. Graph-based models achieved the highest discrimination, with the best AUC reaching approximately 0.61, while classical approaches provided limited predictive value. Cross-sex validation showed minor asymmetry: models trained on male data performed slightly better on female cases than vice versa. Adversarial testing revealed sensitivity of all models to input perturbations. Conclusions: Demographics and comorbidities alone provide insufficient information for reliable PCC prediction. Modest sex-specific differences in model generalizability suggest distinct, sex-associated PCC phenotypes, but richer multimodal data—including clinical biomarkers, wearable-derived measures, and patient-reported outcomes—will be required to develop clinically useful and equitable predictive models. Sex-stratified approaches should be considered in future post-viral syndrome prediction studies.


  • Open Access

    Post-COVID-19 Condition Prediction in Hospitalised Cancer Patients: A Machine Learning-Based Approach

    by Sara Mahvash Mohammadi, Mikhail Rumyantsev, Elina Abdeeva, Dina Baimukhambetova, Polina Bobkova, Yasmin El-Taravi, Maria Pikuza, Anastasia Trefilova, Aleksandr Zolotarev, Margarita Andreeva, et al.

    Background: The COVID-19 pandemic has led to widespread long-term complications, known as post-COVID conditions (PCC), particularly affecting vulnerable populations such as cancer patients. This study aims to predict the incidence of PCC in hospitalised cancer patients using the data from a longitudinal cohort study conducted in four major university hospitals in Moscow, Russia. Methods: Clinical data have been collected during the acute phase and follow-ups at 6 and 12 months post-discharge. A total of 49 clinical features were evaluated, and machine learning classifiers including logistic regression, random forest, support vector machine (SVM), k-nearest neighbours (KNN), and neural network were applied to predict PCC. Results: Model performance was assessed using the area under the receiver operating characteristic curve (AUC), sensitivity, and specificity. KNN demonstrated the highest predictive performance, with an AUC of 0.80, sensitivity of 0.73, and specificity of 0.69. Severe COVID-19 and pre-existing comorbidities were significant predictors of PCC. Conclusions: Machine learning models, particularly KNN, showed some promise in predicting PCC in cancer patients, offering the potential for early intervention and personalised care. These findings emphasise the importance of long-term monitoring for cancer patients recovering from COVID-19 to mitigate PCC impact.